Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 37 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems has received an order to extend the clinical database system and install its new Data Analysis System at the Al Babtain Hospital, Dammam, Saudi Arabia. Dendrite’s unique clinical database system includes four types of analytics and reports:
The positive outcomes from the UK-ROPE (Registry of prostate embolization) – a collaboration initiated by British Society of Interventional Radiology (BSIR) and Dendrite Clinical Systems – has resulted in a National Institute of Health and Care Excellence (NICE) recommendation that prostate artery embolization (PAE) should be made available by the NHS.
Dendrite Clinical Systems and the British Obesity & Metabolic Surgery Society (BOMSS) have launched Version 2 of the National Bariatric Surgical Registry, which includes several enhancements and changes improving the data collected and reporting.
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 36 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems has received an order from NHS Wales to expand the successful Regional Lung Cancer Registry in North Wales to cover the whole of the country, established the Welsh National Lung Cancer Pleural Nodules Registry. The registry is designed for health professionals to collect, view and use real-time data about their patients with pleural disease.
Scientific Advisory Board
Dendrite's Scientific Advisory Board
Professor Sir Bruce Keogh
Sir Bruce Keogh KBE FMedSci FRCS FRCP has had a distinguished international career as a cardiac surgeon. He developed a longstanding interest in clinical outcomes from working closely with Dendrite to establish a national database for adult cardiac surgery early in his surgical career.
He subsequently became chair of Cardiac Surgery at University College London and Director of Surgery at the Heart Hospital, before being appointed Medical Director of the National Health Service and Director General in the Department of Health, a role that later transferred to NHS England. During this period (2007-18) as the most senior doctor in the NHS he was had particular responsibility for the development and implementation clinical policy and strategy across the health service in England. In the Department of Health, he was the Government sponsor for NICE, the Healthcare Commission and the National Patient Safety Agency. He has served on several boards including NHS England.
He is currently Chair of the Birmingham Women’s and Children’s NHS Foundation Trust. He has been ranked as the most influential clinician in the NHS by the HSJ and named as one of Britain’s 500 most influential people in the Sunday Times. He was knighted for Services to Medicine in 2003.
Professor Anthony Goldstone
Professor Anthony Goldstone CBE MA(Oxon) FRCP FRCPE FRCPath is a senior haematology specialist with over 35 years’ experience of working in the NHS. He was appointed as a Consultant at University College Hospital (UCH) in 1976 and initiated the first stages of what became the biggest Adult Haematology unit in the UK.
Professor Goldstone is a former Medical Director of University College London Hospital, former President of the British Society of Haematology and former Chair of the European Society for Blood and Marrow Transplantation Lymphoma Group. He specialises in adult haematology and haematological malignancy, adult leukaemia, lymphoma (Hodgkin's and Non-Hodgkin's Lymphoma) and myeloma and other non-malignant haematological conditions. The founder of the stem cell transplant unit at UCH, Professor Goldstone is a renowned pioneer in haematological stem cell transplantation.
A Principal Investigator on many leukaemia trials in the UK and internationally, he is strong advocate of evidence-based medicine and believes registries now stand alongside randomised clinical trials as real-world evidence. Professor Goldstone, a former Director of the North London Cancer Network, has published over 360 peer-reviewed papers in haematology and has authored three books. He was awarded a CBE June 2008 for Services to Medicine.
